p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Pituitary tumors, often originating in the anterior lobe (AL), affect a significant portion of the population.
• The pituitary gland's susceptibility to genetic alterations involves the cyclin-dependent kinase (CDK) inhibitor (CKI)-CDK-retinoblastoma protein (Rb) pathway.
• Previous studies noted pituitary tumors in Rb-mutant mice but not in CKI-deficient mice, posing a research question.

Purpose of the Study:

• To investigate the role of the CKI gene p19(Ink4d) (p19) in tumor development, particularly in the pituitary anterior lobe.
• To elucidate the mechanisms by which p19 deficiency impacts cell proliferation and tumor formation.
• To establish p19 as a potential tumor suppressor in the context of pituitary AL tumors.

Main Methods:

• Generation and analysis of mice with a deletion in the p19(Ink4d) gene.
• Assessment of tumor development, cell proliferation, and activity of cell cycle regulators (CDK4, CDK6, Rb phosphorylation).
• Examination of p19's role in Cdk4-deficient cells and mouse embryonic fibroblasts (MEFs).

Main Results:

• Mice lacking p19 developed spontaneous tumors in various tissues, with over half exhibiting pituitary hyperplasia or AL tumors.
• Tumorigenesis correlated with increased cell proliferation, elevated Cdk4/Cdk6 activity, and Rb hyperphosphorylation.
• Loss of p19 led to Rb phosphorylation and partially rescued proliferation defects in Cdk4(-/-) pituitary AL cells and MEFs, primarily via Cdk6 activation.

Conclusions:

• p19(Ink4d) functions as a tumor suppressor, demonstrating genetic evidence for its role.
• p19 is identified as a critical CKI gene regulating pituitary anterior lobe cell proliferation.
• The findings provide new insights into the molecular mechanisms underlying pituitary tumor development.